Skip to main content

Table 2 Distributions of the EORTC QLQ-C30 and QLQ-CR29 scores for Taiwanese colorectal cancer patients

From: Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients

Scale N Mean Standard deviation Minimum Maximum Reproducibility
QLQ-C30
 QL2(Q29-Q30) 102 63.9 21.3 0.0 100.0 0.82
 PF(Q1-Q5) 108 81.9 19.0 20.0 100.0 0.81
 RF(Q6-Q7) 107 79.6 25.6 0.0 100.0 0.84
 EF(Q21-Q24) 106 80.9 17.7 25.0 100.0 0.64
 CF(Q20,Q25) 106 79.7 18.0 33.3 100.0 0.48
 SF(Q26,Q27) 106 78.1 22.5 0.0 100.0 0.58
 FA(Q10,Q12,Q18) 107 30.4 20.2 0.0 88.9 0.72
 NV(Q14,Q15) 108 8.2 13.8 0.0 66.7 0.52
 PA(Q9,Q19) 108 17.1 17.6 0.0 83.3 0.11
 DY(Q8) 107 13.1 19.3 0.0 100.0 0.29
 SL(Q11) 106 24.5 26.5 0.0 100.0 0.74
 AP(Q13) 108 16.4 23.0 0.0 100.0 0.59
 CO(Q16) 107 24.3 26.1 0.0 100.0 0.56
 DI(Q17) 106 23.3 29.2 0.0 100.0 0.63
 FI(Q28) 106 15.1 23.5 0.0 100.0 0.47
QLQ-CR29
 BI(Q45-Q47) 105 86.7 19.2 0.0 100.0 0.89
 ANX(Q43) 105 62.9 24.2 0.0 100.0 0.47
 WEI(Q44) 105 74.6 24.3 0.0 100.0 0.48
 SEXF(Q56,Q58) 99 17.5 19.8 0.0 100.0 0.47
 UF(Q31,Q32) 105 21.6 21.4 0.0 100.0 0.51
 BMS(Q38,Q39) 104 11.7 19.1 0.0 100.0 0.34
 SF2(Q52,Q53) 99 20.7 20.8 0.0 83.3 0.78
 UI(Q33) 105 6.3 17.4 0.0 100.0 0.11
 DY2(Q34) 105 2.5 8.9 0.0 33.3 0.69
 AP2(Q35) 105 14.0 21.6 0.0 100.0 0.68
 BP(Q36) 103 10.0 17.4 0.0 66.7 0.71
 BF(Q37) 104 20.5 22.9 0.0 100.0 0.40
 DM(Q40) 105 28.9 20.2 0.0 100.0 0.09
 HL(Q41) 103 17.5 28.7 0.0 100.0 0.85
 TA(Q42) 104 11.2 21.6 0.0 100.0 0.67
 FL(Q49) 101 21.8 26.0 0.0 100.0 0.81
 FI2(Q50) 101 10.6 20.0 0.0 100.0 0.47
 SS(Q51) 98 8.2 16.6 0.0 66.7 0.63
 EMB(Q54) 100 13.7 24.2 0.0 100.0 0.50
 STO(Q55) 13 5.1 12.5 0.0 33.3 0.89
 IMP(Q57) 59 20.3 21.5 0.0 100.0 0.97
 DYS(Q59) 39 9.4 20.2 0.0 66.7 0.65
  1. QL2 global health/quality of life, PF physical function, RF role function, EF emotion function, CF cognitive function, SF social function, FA fatigue, NV nausea/vomiting, PA pain, DY dyspnea, SL insomnia, AP appetite loss, CO constipation, DI diarrhea, FI financial difficulty, BI body image, ANX anxiety, WEI weight, SEXF sexual interest, UF urinary frequency, BMS blood and mucus in stool, SF2 stool frequency, UI urinary incontinence, DY2 dysuria, AP2 abdominal pain, BP buttock pain, BF bloating, DM dry mouth, HL hair loss, TA taste, FL flatulence, FI2 faecal incontinence, SS sore skin, EMB embarrassment, STO stoma care problem, IMP importance, DYS dyspareunia